Australia markets open in 4 hours 27 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
148.41-3.13 (-2.07%)
As of 3:33PM EDT. Market open.
Annual

Cash flow

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Cash flows from operating activities
Net income
15,198
15,198
-179,056
-48,019
-85,653
Depreciation & amortisation
38,744
38,744
33,896
21,984
10,529
Stock-based compensation
32,142
32,142
30,235
7,641
5,909
Change in working capital
-93,097
-93,097
-83,436
-40,961
-7,964
Inventory
-49,794
-49,794
-5,798
-1,253
-574
Accounts payable
204,583
204,583
-
-
-
Other working capital
-98,920
-98,920
-269,617
-126,034
-110,304
Other non-cash items
114,475
114,475
262
-226
-1,403
Net cash provided by operating activities
-13,474
-13,474
-198,537
-58,180
-52,562
Cash flows from investing activities
Investments in property, plant and equipment
-85,446
-85,446
-71,080
-67,854
-57,742
Acquisitions, net
-60,643
-60,643
-6,056
-
0
Other investing activities
-
-
-
1
-
Net cash used for investing activities
-144,848
-144,848
-77,115
-67,148
-52,549
Cash flows from financing activities
Debt repayment
-14,309
-14,309
-3,061
-2,148
-1,643
Common stock issued
753,007
753,007
375,351
361,725
0
Net cash used provided by (used for) financing activities
894,725
894,725
383,290
365,177
-1,643
Net change in cash
736,403
736,403
107,638
239,848
-106,753
Cash at beginning of period
519,149
519,149
411,495
172,106
303,680
Cash at end of period
1,210,209
1,210,209
519,149
411,495
172,106
Free cash flow
Operating cash flow
-13,474
-13,474
-198,537
-58,180
-52,562
Capital expenditure
-85,446
-85,446
-71,080
-67,854
-57,742
Free cash flow
-98,920
-98,920
-269,617
-126,034
-110,304